Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05167734 · ClinicalTrials.gov registry record · Phase 2
Practical Anemia Bundle for SusTained Blood Recovery
A Phase 2 study of Critical Illness and Anemia, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT05167734 is a Phase 2 study of Critical Illness and Anemia that has completed, run by Mayo Clinic. The registered enrollment target is 100 participants, below the 3,137-participant average among 91 other Critical Illness trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05167734, a Phase 2 study of Critical Illness and Anemia, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test a multi-faceted anemia treatment plan to reduce the severity of anemia and to promote hemoglobin and functional recovery in adults who have been in the intensive care unit (ICU).
Conditions Studied
Interventions
- DRUG Iron Dextran
- DRUG Erythropoietin (EPO)
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-11-30 |
| Est. Completion | 2024-11-26 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05167734
The ClinicalTrials.gov registry entry for NCT05167734 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,137-participant average among 91 other Critical Illness trials with a reported enrollment target (97% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Critical Illness appearing as the primary indexed condition, and to 2 interventions - of which Iron Dextran is the first listed.
NCT05167734 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05167734 about?
NCT05167734 is a clinical study titled "Practical Anemia Bundle for SusTained Blood Recovery". The purpose of this study is to test a multi-faceted anemia treatment plan to reduce the severity of anemia and to promote hemoglobin and functional recovery in adults who have been in the intensive care unit (ICU).
What is the current status of trial NCT05167734?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2021-11-30. Estimated completion is 2024-11-26.
What conditions does trial NCT05167734 study?
This clinical trial studies the following conditions: Critical Illness, Anemia.
What interventions are being tested in trial NCT05167734?
The interventions under investigation include: Iron Dextran (DRUG), Erythropoietin (EPO) (DRUG).
Who is sponsoring clinical trial NCT05167734?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05167734 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Critical Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The "What Is Important to Us" Communication Intervention Pilot Clinical Trial
RECRUITING · Phase 2
-
Azithromycin for Critical Asthma - Pediatrics
RECRUITING · Phase 2
-
Hypovitaminosis D in Neurocritical Patients
COMPLETED · Phase 2
-
Inulin for Infections in the Intensive Care Unit
COMPLETED · Phase 2
-
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
RECRUITING · NA
-
Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.